Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
Impilo invests in Swedish HIV diagnostics company Cavidi
February 21, 2018

Impilo has invested in a 29% stake in Cavidi AB, an Uppsala-based diagnostics company focused on HIV Viral Load monitoring. Cavidi has developed a new fully automated viral load diagnostic platform. This platform, Ziva™, aims to meet the need for cost-effective monitoring in high-disease burden countries.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: